# Olema Pharmaceuticals, Inc. (OLMA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Olema Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/OLMA/mda/fy2025/): filed 2026-03-16; accession 0001193125-26-107169 (https://www.sec.gov/Archives/edgar/data/1750284/000119312526107169/olma-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/OLMA/mda/fy2024/): filed 2025-03-18; accession 0000950170-25-041204 (https://www.sec.gov/Archives/edgar/data/1750284/000095017025041204/olma-20241231.htm)
- [FY 2023 MD&A](/company/OLMA/mda/fy2023/): filed 2024-03-11; accession 0000950170-24-029281 (https://www.sec.gov/Archives/edgar/data/1750284/000095017024029281/olma-20231231.htm)
- [FY 2022 MD&A](/company/OLMA/mda/fy2022/): filed 2023-03-09; accession 0001558370-23-003318 (https://www.sec.gov/Archives/edgar/data/1750284/000155837023003318/olma-20221231x10k.htm)
- [FY 2021 MD&A](/company/OLMA/mda/fy2021/): filed 2022-02-28; accession 0001558370-22-002388 (https://www.sec.gov/Archives/edgar/data/1750284/000155837022002388/olma-20211231x10k.htm)

Back to /company/OLMA/